Company Overview and News

 
Citi shares low-tech cash machines to lure customers on the cheap

2017-11-29 reuters
NEW YORK, Nov 29 (Reuters) - Citigroup Inc has plugged into tens of thousands of outside vendors’ cash dispensers across the United States this year, part of a plan to cut costs and entice customers after closing hundreds of branches.
Upvote Downvote

1
5 Bank Stocks Making Their Way Into the Stratosphere

2017-11-28 investorplace
Not even a North Korean ballistic missile launch could keep stocks down on Tuesday, with the Dow Jones Industrial Average up nearly 200 points as I write this.
Upvote Downvote

 
Deals of the day-Mergers and acquisitions

2017-11-28 reuters
(Adds Buffalo Wild Wings, BlackRock, Emerson Electric, HERE, Cineworld Group, Sinopec; updates Bank of Nova Scotia, SoftBank, Mizrahi-Tefahot Bank)
Upvote Downvote

 
Vapid Quant Score Hurt Citigroup (C) Rating

2017-11-28 investorplace
Citigroup Inc (NYSE:C) is ranked as a Hold using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. C has recently seen its Portfolio Grader rating downgraded over the last month from a Buy to a Hold.
Upvote Downvote

 
BlackRock to buy asset management unit of Mexico's Citibanamex

2017-11-28 reuters
NEW YORK (Reuters) - BlackRock Inc (BLK.N) on Tuesday said it had agreed to buy the asset management business of Mexico’s Citibanamex, a subsidiary of Citigroup Inc (C.N), in a sign of the growth potential the world’s largest asset management sees in the country.
Upvote Downvote

 
Rand Bulls Hold Sway, at Least Until ANC's December Ballot - Bloomberg

2017-11-28 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
London’s Startups Stress Out Over Brexit—and Ping Pong - Bloomberg

2017-11-28 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

2
Saudi Prince Who Wooed West Finds Few Friends in Tough Times - Bloomberg

2017-11-28 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Opec clash with US for oil supremacy near day of reckoning

2017-11-28 themalaymailonline
A flag with the Opec logo is seen before a news conference at Opec's headquarters in Vienna December 10, 2016. — Reuters picNEW YORK, Nov 28 — The clash between Opec and America’s oil industry is reaching a day of reckoning.
Upvote Downvote

 
Copper Bulls Are Upbeat Before the Industry’s China Gathering - Bloomberg

2017-11-28 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Bitcoin soars toward $10,000 U.S. mark despite hedge-fund firms warning it’s a fad

2017-11-27 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
South African Rand Surges as Traders Cheer Respite From Moody's - Bloomberg

2017-11-27 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
OPEC clash with U.S. for oil supremacy near day of reckoning

2017-11-27 worldoil
The U.S. shale revolution is on course to be the greatest oil and gas boom in history, turning a nation once at the mercy of foreign imports into a global player. That seismic shift shattered the dominance of Saudi Arabia and the OPEC cartel, forcing them into an alliance with long-time rival Russia to keep a grip on world markets.
Upvote Downvote

 
MOVES-Citi names Brian Ovaert global head of securities services

2017-11-27 reuters
Nov 27 (Reuters) - Citigroup Inc, the fourth-largest U.S. bank by assets, on Monday named Brian Ovaert managing director and global head of securities services and issuer services operations.
Upvote Downvote

 
Foreign Stock Roundup: BP Buys Cairn Energy Stake, Honda to Recall 900K Minivans

2017-11-27 zacks
Germany’s political crisis weighed on Europe’s indexes throughout last week even as automobile stocks emerged the largest gainers. In Asia, China’s stocks suffered steep losses even as the Hang Seng breached the 30,000 barrier. Meanwhile, Chile’s stocks were weighed down by concerns surrounding presidential elections. Investors in Brazil remained apprehensive about the prospects of pension reforms.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...